U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515456) titled 'Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache' on March 31.
Brief Summary: The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.
Study Start Date: Dec. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Theophylline
Sumatriptan
Gabapentin
Post-Dural Puncture Headache
Intervention:
DRUG: Theophylline
Patients included in this group will receive oral 150 mg theophylline anhydrous tablet (QuibronT/SR, 300 mg dividose tablet, SmithKline Beecham Egypt L.L.C) every 12 hours.
DRUG: Suma...